Zimmer Biomet Holdings, Inc. (ZBH) Holdings Held by Prudential PLC

Prudential PLC continued to hold its position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,700 shares of the medical equipment provider’s stock at the end of the 2nd quarter. Prudential PLC’s holdings in Zimmer Biomet Holdings were worth $1,117,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently bought and sold shares of the company. Bronfman E.L. Rothschild L.P. raised its position in Zimmer Biomet Holdings by 25.3% in the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 827 shares of the medical equipment provider’s stock worth $106,000 after purchasing an additional 167 shares during the period. Parkside Financial Bank & Trust raised its position in Zimmer Biomet Holdings by 3.9% in the 2nd quarter. Parkside Financial Bank & Trust now owns 872 shares of the medical equipment provider’s stock worth $112,000 after purchasing an additional 33 shares during the period. Parallel Advisors LLC raised its position in Zimmer Biomet Holdings by 20.8% in the 1st quarter. Parallel Advisors LLC now owns 1,157 shares of the medical equipment provider’s stock worth $138,000 after purchasing an additional 199 shares during the period. IHT Wealth Management LLC raised its position in Zimmer Biomet Holdings by 28.4% in the 1st quarter. IHT Wealth Management LLC now owns 1,158 shares of the medical equipment provider’s stock worth $139,000 after purchasing an additional 256 shares during the period. Finally, Sandy Spring Bank raised its position in Zimmer Biomet Holdings by 1.7% in the 1st quarter. Sandy Spring Bank now owns 1,222 shares of the medical equipment provider’s stock worth $149,000 after purchasing an additional 20 shares during the period. 85.36% of the stock is currently owned by institutional investors.

A number of research firms recently weighed in on ZBH. SunTrust Banks, Inc. reissued a “buy” rating and issued a $136.00 price objective on shares of Zimmer Biomet Holdings in a research report on Monday, October 2nd. Zacks Investment Research raised shares of Zimmer Biomet Holdings from a “sell” rating to a “hold” rating in a research report on Tuesday, September 26th. Gabelli began coverage on shares of Zimmer Biomet Holdings in a research report on Thursday, August 24th. They issued a “buy” rating and a $142.00 price objective on the stock. Oppenheimer Holdings, Inc. set a $137.00 price objective on shares of Zimmer Biomet Holdings and gave the stock a “buy” rating in a research report on Monday, August 14th. Finally, BidaskClub lowered shares of Zimmer Biomet Holdings from a “hold” rating to a “sell” rating in a research report on Tuesday, August 1st. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the stock. Zimmer Biomet Holdings presently has an average rating of “Hold” and an average target price of $136.55.

Zimmer Biomet Holdings, Inc. (ZBH) opened at 118.41 on Wednesday. The stock’s 50 day moving average is $115.42 and its 200-day moving average is $120.40. Zimmer Biomet Holdings, Inc. has a 1-year low of $95.63 and a 1-year high of $133.49. The company has a market capitalization of $23.94 billion, a P/E ratio of 33.73 and a beta of 1.19.

Zimmer Biomet Holdings (NYSE:ZBH) last announced its earnings results on Thursday, July 27th. The medical equipment provider reported $2.08 earnings per share for the quarter, missing the consensus estimate of $2.10 by ($0.02). Zimmer Biomet Holdings had a return on equity of 16.70% and a net margin of 9.12%. The business had revenue of $1.95 billion for the quarter, compared to analysts’ expectations of $1.95 billion. During the same period in the previous year, the company earned $2.02 earnings per share. Zimmer Biomet Holdings’s quarterly revenue was up 1.1% on a year-over-year basis. On average, analysts expect that Zimmer Biomet Holdings, Inc. will post $8.23 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, September 22nd will be paid a dividend of $0.24 per share. This represents a $0.96 annualized dividend and a yield of 0.81%. The ex-dividend date is Thursday, September 21st. Zimmer Biomet Holdings’s payout ratio is currently 27.59%.

TRADEMARK VIOLATION WARNING: This article was first reported by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this article on another site, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The correct version of this article can be viewed at https://sportsperspectives.com/2017/10/11/zimmer-biomet-holdings-inc-zbh-holdings-held-by-prudential-plc.html.

In related news, VP Tony W. Collins sold 16,986 shares of the company’s stock in a transaction that occurred on Monday, July 31st. The shares were sold at an average price of $121.74, for a total transaction of $2,067,875.64. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 1.07% of the stock is owned by corporate insiders.

Zimmer Biomet Holdings Company Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings, Inc. (NYSE:ZBH).

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply